An observational study of alemtuzumab following fingolimod for multiple sclerosis.
published in: Neurology(R) neuroimmunology & neuroinflammation
date of publication: 2017-01-10
main subject: multiple sclerosis
Cites articles 10
- 2016-09-01
- 2012-01-01
Date
Title
Article - wd:Q37579941